LIPOCINE INC. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- LIPOCINE INC. stock issued during period, value, new issues for the quarter ending 2026-06-30 was $1.51M, a 1893.89% increase year-over-year.
- LIPOCINE INC. stock issued during period, value, new issues for the quarter ending 2026-03-31 was $11.96M.
- LIPOCINE INC. stock issued during period, value, new issues for the quarter ending 2025-12-31 was $2.65M.
- LIPOCINE INC. stock issued during period, value, new issues for the quarter ending 2025-09-30 was $141.33K.
- LIPOCINE INC. stock issued during period, value, new issues for fiscal 2025 was $2.87M, a 1270.76% increase from fiscal 2024.
- LIPOCINE INC. stock issued during period, value, new issues for fiscal 2024 was $209.34K, a 48.26% decline from fiscal 2023.
- LIPOCINE INC. stock issued during period, value, new issues for fiscal 2023 was $404.57K.
- LIPOCINE INC. stock issued during period, value, new issues for fiscal 2021 was $3.41M, a 62.17% decline from fiscal 2020.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2026-06-30 | $1.51M 10-Q · filed 2026-08-04 | $16.27M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $11.96M 10-Q · filed 2026-05-07 | $14.83M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $2.65M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $2.87M 10-K · filed 2026-03-10 |
| 2025-09-30 | $141.33K 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $75.62K 10-Q · filed 2026-08-04 | |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $209.34K 10-K · filed 2026-03-10 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | |
| 2024-06-30 | $217.44K 10-Q · filed 2024-08-08 | |
| 2023-12-31 | -$5.30K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | $404.57K 10-K · filed 2025-03-13 |
| 2023-09-30 | $421.08K 10-Q · filed 2024-11-07 | |
| 2021-12-31 | -$5.13K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-10 | $3.41M 10-K · filed 2023-03-10 |
| 2021-09-30 | -$4.93K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $8.52M derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | -$5.28K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $12.43M derived: sum of 4 quarters · filed 2022-08-08 |
| 2021-03-31 | $3.42M 10-Q · filed 2022-05-09 | |
| 2020-12-31 | $5.11M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-09 | $9.00M 10-K · filed 2022-03-09 |
| 2020-09-30 | $3.90M 10-Q · filed 2021-11-10 | |
| 2019-09-30 | $603.68K 10-Q · filed 2019-11-12 | $7.51M derived: sum of 4 quarters · filed 2019-11-12 |
| 2019-06-30 | $281.23K 10-Q · filed 2019-08-07 | $7.00M derived: sum of 4 quarters · filed 2019-11-12 |
| 2019-03-31 | $6.06M 10-Q · filed 2019-05-08 | |
| 2018-12-31 | $561.57K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-06 | $652.33K 10-K · filed 2019-03-06 |
| 2018-09-30 | $90.76K 10-Q · filed 2019-11-12 | |
| 2017-12-31 | -$455.12K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-06 | $10.64M 10-K · filed 2019-03-06 |
| 2017-09-30 | $2.30M 10-Q · filed 2018-11-07 | |
| 2017-06-30 | $5.90M 10-Q · filed 2018-08-07 | |
| 2017-03-31 | $2.90M 10-Q · filed 2018-05-07 | |
| 2015-12-31 | $32.44M 10-K · filed 2018-03-12 | |
| 2013-12-31 | $12.54M 10-K · filed 2015-03-11 | |
| 2012-12-31 | -$50.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-26 | $40.45K 10-K · filed 2013-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |